< 返回主頁

Clinicians Call for Easing FDA Warnings on Low-Dose Estrogen

by | May 14, 2024 | Metabolic Syndrome, News & Commentary

By Kerry Dooley Young

Source Medscape

Many women fear taking these vaginal products due to what Powell considers excessively strong warnings about the risk for cancer and cardiovascular disease linked to daily estrogen pills that were issued in the early 2000s.

He is advocating for the US Food and Drug Administration (FDA) to remove the black box warning on low-dose estrogen. His efforts are separate from his roles as an associate professor of urology at the Indiana University School of Medicine, Indiana, and as a member of the American Urological Association (AUA), Powell said.

Read more https://www.medscape.com/viewarticle/clinicians-call-easing-fda-warnings-low-dose-estrogen-2024a100093t?ecd=WNL_mdpls_240517_mscpedit_fmed_etid6524709&uac=362093AT&spon=34&impID=6524709